Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Celltrion | Seoul | Healthcare | Biotechnology & Medical Research | ₩39.33T | 193.1x | -2.75 | ₩181,700 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 31% Upside | Upgrade to Pro+ | |
LigaChem Biosciences | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩3.88T | -1,200.5x | -13.39 | ₩104,900 | -2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 49.5% Upside | Upgrade to Pro+ | |
TissueGene | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩3.26T | ₩39,150 | -2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Voronoi | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩2.55T | -35.3x | 9.45 | ₩138,100 | -2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Peptron | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩2.09T | -108.9x | 15.24 | ₩87,600 | -2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ABL Bio | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩1.91T | -29.4x | 0.07 | ₩38,450 | -2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 20.3% Upside | Upgrade to Pro+ | |
Seegene | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩1.13T | 37.6x | 0.03 | ₩23,900 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
OliX Pharmaceuticals | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩847.29B | -13.2x | 1.72 | ₩43,700 | -4.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
GI Innovation | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩707.55B | ₩15,790 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Genomictree | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩461.81B | -42.3x | -11.2 | ₩18,650 | -3.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Curocell | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩413.2B | ₩28,500 | -2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
AprilBio | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩384.29B | ₩16,520 | -3.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Bioneer | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩371.41B | -18.2x | 0.02 | ₩13,990 | -2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SillaJen | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩330.19B | -10.9x | 1.5 | ₩2,350 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ToolGen | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩322.05B | -6.8x | 0.03 | ₩36,500 | -3.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medipost | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩289.5B | -42.6x | 0.03 | ₩8,350 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bridge Bio | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩257.82B | -4.1x | -0.34 | ₩4,930 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
PharmAbcine | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩233.76B | -0.45 | ₩2,915 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Curiox BioSystems | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩228.8B | -25.7x | -1.06 | ₩13,810 | -2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Amicogen | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩203.64B | -5.1x | -0.72 | ₩3,645 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Vaxcell | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩203.49B | -25x | -21.84 | ₩8,600 | -2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
AptaBio Therapeutics | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩193.55B | -9.3x | 0.19 | ₩7,060 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Genexine | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩189.65B | -4.3x | -0.06 | ₩4,095 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ENCell | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩184.86B | ₩16,370 | -4.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
HLB BioStep | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩184.81B | -35.1x | 0.17 | ₩2,235 | 1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Orientbio | Seoul | Healthcare | Biotechnology & Medical Research | ₩179.04B | -26.4x | ₩1,499 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
3Billion | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩173.63B | ₩5,270 | -3.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
NKMAX | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩172.74B | 31.1x | 0.07 | ₩2,020 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Abion | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩172.68B | -3.4x | 0.08 | ₩5,800 | -3.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
GeneOne Life Science | Seoul | Healthcare | Biotechnology & Medical Research | ₩164.85B | -2.3x | 0.06 | ₩2,035 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nibec | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩157.95B | ₩14,190 | -2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Macrogen | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩151.48B | -7.7x | -2.91 | ₩14,970 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Onconic Therapeutics | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩148.01B | ₩13,130 | -4.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
CJ Bioscience | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩145.55B | -4.7x | ₩11,070 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
DNA Link | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩137.96B | -10x | 0.2 | ₩5,900 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
HEM Pharma | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩130.96B | ₩18,440 | -2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
iNtRON Biotechnology | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩127.59B | -39.5x | -0.52 | ₩3,975 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medpacto | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩121.33B | -6.3x | -0.13 | ₩3,435 | -3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Panagene | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩114.38B | -10.9x | ₩2,645 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Kang Stem Biotech | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩112.95B | -11.6x | -0.15 | ₩1,972 | -2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
OnCoCross | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩110.5B | -22.9x | 2.06 | ₩9,180 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Shaperon | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩99.47B | -5.2x | 0.25 | ₩3,200 | -3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cytogen | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩98.74B | -6.6x | -0.34 | ₩4,185 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Curacle Co | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩96.15B | -5.3x | 0.12 | ₩6,770 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Noul | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩95.69B | -5x | -0.24 | ₩2,485 | -4.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pharos IBio | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩92.69B | -9.6x | 4.13 | ₩7,000 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cell Biotech | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩91.57B | 8.9x | 0 | ₩13,210 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Tiumbio | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩89.35B | -5.5x | -0.12 | ₩3,300 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cellid | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩86.63B | -8.1x | -0.17 | ₩4,060 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Corestem | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩85.14B | -7.8x | 0.01 | ₩3,425 | -2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |